Rituximab with high-dose methotrexate is effective and cost-effective in newly diagnosed primary central nervous system lymphoma

Induction chemotherapy based on high-dose methotrexate is considered as the standard approach for newly diagnosed primary central nervous system lymphomas (PCNSLs). However, the best combination chemotherapeutic regimen remains unclear. This study aimed to determine the efficacy and toxicities of ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Xianggui, Yu, Teng, Huang, Yurong, Jiang, Huawei, Xu, Xiaohua, Liang, Yun, Qian, Wenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747713/
https://www.ncbi.nlm.nih.gov/pubmed/36513674
http://dx.doi.org/10.1038/s41598-022-24922-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747713/
https://www.ncbi.nlm.nih.gov/pubmed/36513674
http://dx.doi.org/10.1038/s41598-022-24922-y

Ejemplares similares